Finanztrends
Beximco Pharmaceuticals Ltd. GDR Aktie
Stabile Lage: Der Kurs der Beximco Pharmaceuticals Ltd. GDR Aktie bleibt seit gestern gleich.
Was spricht für und gegen Beximco Pharmaceuticals Ltd. GDR in den nächsten Jahren?
Pro
?
L*********** I********** f** d** n******* J****
?
W******* i* V********
?
M****
Kontra
?
A****************
?
M************
?
U****************
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Beximco Pharmaceuticals Ltd. GDR im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | 0,00 % | -26,21 % | -15,18 % | -11,63 % | -15,18 % | -21,49 % | -63,11 % |
| Eledon Pharmaceuticals Inc. | -2,79 % | -5,95 % | 35,94 % | -60,99 % | 35,94 % | -42,00 % | -85,08 % |
| SELLAS Life Sciences Group Inc | -3,69 % | -11,89 % | 12,35 % | 148,05 % | 12,35 % | 2,61 % | -36,43 % |
| JCR Pharmaceuticals Co Ltd | -4,55 % | -7,69 % | -11,11 % | -2,89 % | -11,11 % | - | - |
Kommentare
News
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%